Healthcare systems worldwide are under immense pressure to deliver cost-effective, value-based care to an aging population, often beset with complex lifestyle-related chronic illnesses.
Sustainability requires a shift in focus from episodic to continuous care, where patients monitor their health and co-manage their treatment remotely.
We help healthcare companies develop digital health solutions that leverage recent advancements in connectivity and data science for competitive advantage.
Smart connected devices
We have a proven track record developing both consumer and medical connected devices and establishing the infrastructure that allows our clients to harness their data.
Having developed the world's first single-chip Bluetooth solution – now used in over 70% of all smartphones – our more recent breakthroughs include the first 24/7 wrist-worn activity monitor, the first wireless pacemaker, the first wireless patient monitor and the first connected inhaler.
Digital health strategy
We provide strategic advice on long-term strategic roadmaps, business system integration, digital transformation and go-to-market strategies.
We can assist across the entire digital health journey including: creating compelling strategies and strong stories for investors; shaping the teams and partnerships needed to support digital services; rapid prototyping of service offerings; and roadmap innovation and development.
Interested in joining us?
Tech, tools & facilities
Satimo Stargate 64
This anechoic radio and antenna test chamber is one of only a handful of facilities in Europe. Within this six-metre cube, we can carry out automated three-dimensional measurement and visualisation of wireless device behaviour and test body-worn technology using body phantoms or real live test subjects. This helps us to understand and optimise real-word RF performance of products such as smart implants (including implanted telemetry), connected drug delivery devices and wearables.
Life science labs
Our suite of restricted Class II laboratories are specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.
Our electronic and mechanical prototyping workshops allow us to produce technically credible prototypes that bring ideas to life and offer a powerful demonstration of their value. All while maintaining extremely high standards of quality that conform to ISO 9001, ISO 13485 and ISO 14001 regulations. Using the latest CNC and milling machines, lathes, welding gear and wire harness and cable assembly tools, we are able to produce parts very quickly and assemble full-scale working prototypes for testing and consumer trials.
Surgical innovation suite
Equipped to simulate clinical, home and office environments, this facility allows us to test concepts, evaluate prototypes and analyse workflows in a safe and confidential setting. It’s an invaluable tool for understanding and communicating the contextual implications of design decisions, while the ability to conduct quick-turnaround usability evaluations means we can efficiently progress design and development.
The Digital Greenhouse is our purpose-built AI research facility, specifically designed to discover, develop and test machine learning approaches in a fast, secure environment. The facility features an NVIDIA DGX-1 Deep Learning Supercomputer, a bank of machine learning computers, petabyte local storage and many teraflops of dedicated compute power.
An empowering design solution addressing unmet needs
A major milestone, enabled by our breakthrough sensing technology.
A visionary medical device, beautiful and effortless to use
A world-first for endovascular bleed detection
News & insights
Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator
Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices
Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings.
- AI & Analytics
- Connectivity & IoT
- Digital health
- Signal processing
The what, why and how of connected medical implant development for personalized delivery of medicine
The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.
- Connectivity & IoT
- Digital health
- Product realisation